OverviewSuggest Edit

GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. To address these therapeutic areas, the Company leverages its integrated development platform by combining a gene therapy-based approach with its core technology platforms of mitochondrial targeting sequence and optogenetics.

GenSight's initial focus has been on developing therapies for severe retinal diseases, with the goal of preserving or restoring vision in patients suffering from sight-threatening ophthalmic diseases.

HQParis, FR

Latest Updates

Employees (est.) (Feb 2019)37
Share Price (Oct 2017)€5.2

Key People/Management at GenSight Biologics

Bernard Gilly

Bernard Gilly

CEO and Co-Founder
Thomas Gidoin

Thomas Gidoin

Barrett Katz

Barrett Katz

Chief Medical Officer
Julio Benedicto

Julio Benedicto

Vice President, Marketing
Michael Wyzga

Michael Wyzga

Botond Roska

Botond Roska

Show more

GenSight Biologics Office Locations

GenSight Biologics has offices in Paris and New York
Paris, FR (HQ)
74 Rue du Faubourg Saint-Antoine
New York, US
3 E 28th St
Show all (2)

GenSight Biologics Financials and Metrics

GenSight Biologics Revenue

Market capitalization (31-Oct-2017)


Closing stock price (31-Oct-2017)

GenSight Biologics's current market capitalization is €101.7 m.
Show all financial metrics

GenSight Biologics Online and Social Media Presence

Embed Graph

GenSight Biologics Blogs

EVER 2019, Nice (FR)

GenSight Biologics reports evidence of GS010 DNA transfer to contralateral eye of primates unilaterally injected with GS010 Gene Therapy

First study to find direct evidence that therapeutic gene is transferred from the injected eye to the uninjected contralateral eye of primates Findings support mechanism for bilateral visual improvement with unilateral GS010 gene therapy, which was consistently observed in LHON subjects in the …
Show more

GenSight Biologics Frequently Asked Questions

  • When was GenSight Biologics founded?

    GenSight Biologics was founded in 2011.

  • Who are GenSight Biologics key executives?

    GenSight Biologics's key executives are Bernard Gilly, Thomas Gidoin and Barrett Katz.

  • How many employees does GenSight Biologics have?

    GenSight Biologics has 37 employees.

  • Who are GenSight Biologics competitors?

    Competitors of GenSight Biologics include Touchlight Genetics, Blueprint Genetics and Osiris Therapeutics.

  • Where is GenSight Biologics headquarters?

    GenSight Biologics headquarters is located at 74 Rue du Faubourg Saint-Antoine, Paris.

  • Where are GenSight Biologics offices?

    GenSight Biologics has offices in Paris and New York.

  • How many offices does GenSight Biologics have?

    GenSight Biologics has 2 offices.